Cargando…
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late onset neurodegenerative disorder that is characterized by tremor, cerebellar ataxia, frequent falls, cognitive decline, and progressive loss of motor function. There are currently no approved treatments for this disorder. The purpose of t...
Autores principales: | Hall, Deborah A., Robertson, Erin E., Leehey, Maureen, McAsey, Andrew, Ouyang, Bichun, Berry-Kravis, Elizabeth, O’Keefe, Joan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018079/ https://www.ncbi.nlm.nih.gov/pubmed/32053612 http://dx.doi.org/10.1371/journal.pone.0225191 |
Ejemplares similares
-
Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor
por: Robertson, Erin E., et al.
Publicado: (2020) -
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
por: Hagerman, Randi J, et al.
Publicado: (2008) -
New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype
por: Fraint, Avram, et al.
Publicado: (2014) -
Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
por: Salcedo-Arellano, Maria Jimena, et al.
Publicado: (2023) -
Emerging topics in FXTAS
por: Hall, Deborah A, et al.
Publicado: (2014)